OXFORD, MS—The 13th Annual Oxford International Conference on the Science & Regulation of Botanicals (ICSB) will discuss important topics to the dietary supplement industry including adverse event reporting, the safety and science of botanicals, modern analytical techniques.

The event, held April 15 to 17 in Oxford, MS, is supported by FDA's division of dietary supplement programs as well as sponsors such as the United Natural Products Alliance (UNPA).

Daniel Fabricant, Ph.D., director, division of dietary supplement programs, FDA, will join Loren  Israelsen, president, UNPA, and Mark Blumenthal, founder and executive director of the American Botanical Council (ABC) for a panel discussion the safety, science and quality of botanicals 20 years after the Dietary Supplement Health and Education Act of 1994 (DSHEA). Read a reflection of DSHEA with Israelsen in INSIDER's "Past, Present and Future of DSHEA" Digital Issue.

Other FDA officials will give presentations at ICSB including Angela F. Pope, Ph.D., consumer safety officer, GMP team; Cara Welch, PhD, regulatory special assistant, division of dietary supplement programs; and Charles Wu, Ph,D., Pharmacologist; the FDA officials will hold a panel discussion on current and future FDA priorities, including AERs, GMPs (good manufacturing practices) and botanical drug development.

Other speakers include Steve Mister, president and CEO of the Council for Responsible Nutrition (CRN); Andrew T. O'Hare, CAE, senior vice president government affairs, chief operating officer, Natural Products Association (NPA); Maged Sharaf, chief science officer, American Herbal Products Association (AHPA) and many more from industry, media and academia.

Other topics that will be covered include an update on the ABC adulterants program, communications to supplement consumers and new developments in China.

This event is for anyone involved in dietary supplement research, manufacturing, quality management, regulatory and executive management.